JOURNAL OF CHEMICAL RESEARCH 2007 731
Compound 2i: IR (film): ν (cm-1) 2958, 2160, 1724, 1604, 1277,
1109, 860, 844, 770; 1H NMR (CDCl3): δ 7.96 (m, J* = 8.4 Hz,
2H), 7.52 (m, J* = 8.4 Hz, 2H), 3.91 (s, 3H), 0.26 (s, 9H); 13C NMR
(CDCl3): δ 166.5, 131.9, 129.7, 129.4, 127.8, 104.1, 97.7, 52.2, –0.17;
MS: m/z 232 (M+, 79), 218 (81), 217 (100), 201 (53), 158 (45); Anal.
Calc. for C13H16SiO2: C, 67.19; H, 6.94. Found: C, 67.35; H, 6.9%.
Compound 2j: IR (film): ν (cm-1) 2962, 2169, 1572, 1532, 1353,
1251, 845; 1H NMR (CDCl3): δ 8.31 (s, 1H), 8.17–8.14 (m, 1H),
7.76–7.73 (m, 1H), 7.48 (t, J = 8.0 Hz, 1H), 0.26 (s, 9H); 13C NMR
(CDCl3): δ 148.0, 137.5, 129.2, 126.8, 125.0, 123.1, 102.2, 97.6,
-0.27; MS: m/z 219 (M+, 11), 204 (100), 183 (57); Anal. Calc. for
C11H13NSiO2: C, 60.24; H, 5.98. Found: C, 59.95; H, 5.8%.
Compound 2k: IR (film): ν (cm-1) 2960, 2151, 1602, 1579, 1483,
1250, 843; 1H NMR (CDCl3): δ 7.30–7.25 (m, 2H), 7.18 (t, J = 7.6 Hz,
1H), 7.12 (d, J = 7.6 Hz, 1H), 2.31 (s, 3H), 0.24 (s, 9H); 13C NMR
(CDCl3): δ 137.8, 132.5, 129.3, 128.9, 128.0, 122.8, 105.2, 93.6, 21.0,
–0.12; MS: m/z 188 (M+, 73), 173 (100); Anal. Calc. for C12H16Si: C,
76.53; H, 8.56. Found: C, 76.7; H, 8.4%.
1574, 670; 1H NMR (CDCl3): δ 7.38 (m, J* = 8.0 Hz, 2H), 7.12 (m,
J* = 8.0 Hz, 2H), 3.03 (s, 1H), 2.35 (s, 3H); 13C NMR (CDCl3):
δ 139.0, 132.0, 129.1, 119.0, 104.2, 83.8, 21.5; MS (EI): m/z 116
(M+, 23), 101 (45), 97 (51), 91 (64), 71 (68), 69 (80), 57 (100). Anal.
Calcd for C9H8: C, 93.06; H, 6.94. Found: C, 92.8; H, 6.75.
Compound 3g: IR (film): ν (cm-1) 3289, 2154, 1609, 1585, 1510,
1
1261, 1093, 836; H NMR (CDCl3): δ 7.41 (m, J* = 8.4 Hz, 2H),
6.80 (m, J* = 8.4 Hz, 2H), 4.93 (br, 1H), 3.02 (s, 1H); 13C NMR
(CDCl3): δ 156.3, 133.8, 115.5, 114.2, 104.3, 83.7; MS: m/z 118 (M+,
100), 93 (89), 77 (56). Anal. Calcd for C8H6O: C, 81.34; H, 5.12.
Found: C, 81.6; H, 5.35.
Compound 3h: IR (film): ν (cm-1) 3282, 2926, 2162, 1686, 1595,
1494, 761; 1H NMR (CDCl3): δ 7.91 (m, J* = 8.4 Hz, 2H), 7.57
(m, J* = 8.4 Hz, 2H), 3.25 (s, 1H), 2.61 (s, 3H); 13C NMR (CDCl3):
δ 197.3, 136.8, 132.3, 128.2, 126.9, 82.8, 80.3, 26.6; MS: m/z 144
(M+, 86), 129 (100), 101 (91), 85 (64), 71 (75), 57 (85). Anal. Calcd
for C10H8O: C, 83.31; H, 5.59. Found: C, 83.05; H, 5.3.
Compound 3i: IR (film): ν (cm-1) 3290, 2925, 1725, 1608, 1278,
1109, 696; 1H NMR (CDCl3): δ 7.99 (m, J* = 8.4 Hz, 2H), 7.55
(m, J* = 8.4 Hz, 2H), 3.92 (s, 3H), 3.23 (s, 1H); 13C NMR (CDCl3):
δ 166.4, 132.1, 130.2, 129.5, 126.8, 82.8, 80.0, 52.3; MS: m/z 160
(M+, 57), 146 (32), 129 (100), 101 (71), 75 (34). Anal. Calcd for
C10H8O2: C, 74.99; H, 5.03. Found: C, 74.75; H, 4.8.
Compound 2l: IR (film): ν (cm-1) 2957, 2236, 2151, 1594, 1571,
1476, 1248, 846; 1H NMR (CDCl3): δ 7.74 (s, 1H), 7.65 (d, J = 8.0 Hz,
1H), 7.58 (d, J = 8.0 Hz, 1H), 7.42 (t, J = 8.0 Hz, 1H), 0.26 (s, 9H);
13C NMR (CDCl3): δ 135.8, 135.2, 131.5, 129.0, 124.7, 117.9, 112.7,
102.2, 97.3, -0.36; MS: m/z 199 (M+, 31), 83 (46), 71 (63), 57 (100);
Anal. Calc. for C12H13NSi: C, 72.31; H, 6.57. Found: C, 72.1; H,
6.3%.
Compound 3j: IR (film): ν (cm-1) 3289, 2119, 1574, 1530, 1473,
1352, 807, 736; 1H NMR (CDCl3): δ 8.34 (s, 1H), 8.22–8.19 (m, 1H),
7.81–7.78 (m, 1H), 7.52 (t, J = 8.0 Hz, 1H), 3.22 (s, 1H); 13C NMR
(CDCl3): δ 148.1, 137.8, 129.4, 127.0, 124.0, 123.6, 81.1, 79.9; MS:
m/z 147 (M+, 89), 123 (34), 111 (42), 101 (100), 77 (45), 75 (65), 57
(48). Anal. Calcd for C8H5NO2: C, 65.31; H, 3.43. Found: C, 65.45;
H, 3.5.
Compound 2m: IR (film): ν (cm-1) 2962, 2147, 1706, 1565, 1393,
1261, 843, 799; 1H NMR (CDCl3): δ 8.33 (d, J = 8.4 Hz, 1H), 7.85–
7.81 (m, 2H), 7.71–7.69 (m, 1H), 7.58–7.51(m, 2H), 7.43–7.38 (m,
1H), 0.34 (s, 9H); 13C NMR (CDCl3): δ 133.3, 133.0, 130.7, 128.9,
128.1, 126.7, 126.3, 126.1, 125.0, 120.7, 103.0, 99.4, 0.0; MS: m/z
224 (M+, 3.8), 127 (26), 91 (51), 77 (62), 64 (100); Anal. Calc. for
C15H16Si: C, 80.29; H, 7.19. Found: C, 80.0; H, 7.35%.
Compound 3k: IR (film): ν (cm-1) 3291, 2922, 2381, 1631, 1463,
1
758; H NMR (CDCl3): δ 7.32–7.16 (m, 4H), 3.04 (s, 1H), 2.33 (s,
Compound 2n: IR (film): ν (cm-1) 2961, 2147, 1250, 1164, 844,
699; 1H NMR (CDCl3): δ 7.26–7.22 (m, 2H), 6.95 (t, J = 4.4 Hz, 1H),
0.25 (s, 9H); 13C NMR (CDCl3): δ 132.7, 127.4, 127.0, 123.4, 98.9,
97.7, 0.13; MS: m/z 180 (M+, 15), 165 (56), 73 (100); Anal. Calc. for
C9H12SSi: C, 59.94; H, 6.71. Found: C, 59.7; H, 6.5%.
3H); 13C NMR (CDCl3): δ 138.0, 132.7, 129.7, 129.2, 128.2, 121.9,
104.2, 83.8, 21.2; MS: m/z 116 (M+, 19), 101 (54), 97 (61), 85 (67),
71 (84), 57 (100). Anal. Calcd for C9H8: C, 93.06; H, 6.94. Found: C,
93.2; H, 7.1.
Compound 3l: IR (film): ν (cm-1) 3293, 2233, 2109, 1641, 1594,
1573, 800; 1H NMR (CDCl3): δ 7.78–7.61 (m, 3H), 7.45 (t, J = 8.0 Hz,
1H), 3.19 (s, 1H); 13C NMR (CDCl3): δ 136.2, 135.5, 132.1, 129.3,
123.8, 117.9, 113.0, 81.2, 79.8; MS: m/z 127 (M+, 100), 101 (84),
75 (41). Anal. Calcd for C9H5N: C, 85.02; H, 3.96. Found: C, 84.8;
H, 3.8.
General procedure for the synthesis of terminal arylacetylenes 3a–n
A mixture of 1-aryl-2-(trimethylsilyl)ethyne (1.0 mmol), anhydrous
potassium carbonate (0.09 mmol) in anhydrous MeOH (3 ml) was
stirred at 25°C under argon for 3 h. The solvent was evaporated
under reduced pressure, and the residue was mixed with 2 ml of
aqueous sodium bicarbonate and extracted with Et2O (3 × 10 ml).
The combined organic fractions were dried over MgSO4, and
concentrated. The residue was purified by flash chromatography on
silica gel (light petroleum:ethyl acetate = 2:1 for 3g; light petroleum
for 3a, 3b, 3c, 3f, 3k, 3m, 3n; light petroleum: ethyl acetate = 9:1 for
3d, 3e, 3h, 3i, 3j, 3l).
Compound 3m: IR (film): ν (cm-1) 3292, 3058, 2102, 1586, 1508,
800, 773; 1H NMR (CDCl3): δ 8.37–8.35 (m, 1H), 7.85 (d, J = 8.0 Hz,
2H), 7.75–7.72 (m, 1H), 7.59-7.40 (m, 3H), 3.47 (s, 1H); 13C NMR
(CDCl3): δ 133.5, 133.1, 131.2, 129.3, 128.3, 127.0, 126.5, 126.1,
125.1, 119.8, 81.9, 81.8; MS: m/z 152 (M+, 23), 127 (68), 83 (59), 69
(64), 57 (100). Anal. Calcd for C12H8: C, 94.70; H, 5.30. Found: C,
94.5; H, 5.2.
Compound 3a: IR (film): ν (cm-1) 3292, 2110, 1598, 1574, 1488,
757, 691; 1H NMR (CDCl3): δ 7.51–7.48 (m, 2H), 7.35–7.32 (m,
3H), 3.08 (s, 1H); 13C NMR (CDCl3): δ 132.1, 128.8, 128.3, 122.1,
83.7, 77.1. MS: m/z 102 (M+, 43), 77 (65), 57 (100).
Compound 3n: IR (film): ν (cm-1) 3290, 2143, 1631, 1463, 1117,
700; 1H NMR (CDCl3): δ 7.34–7.27 (m, 2H), 7.01–6.98 (m, 1H), 3.33
(s, 1H); 13C NMR (CDCl3): δ 133.1, 128.9, 127.2, 122.5, 81.2, 77.4;
MS: m/z 108 (M+, 100), 83 (48). Anal. Calcd for C6H4S: C, 66.63; H,
3.73. Found: C, 66.4; H, 3.7.
Compound3b:IR(film):ν(cm-1)3287,2346,1583,1489,1462,758;
1H NMR (CDCl3): δ 7.46 (m, J* = 8.8 Hz, 2H), 7.35 (m, J* = 8.8 Hz,
2H), 3.12 (s, 1H). 13C NMR (CDCl3): δ 133.6, 131.6, 123.1, 121.1,
82.6, 78.3. MS: m/z 182 (M+, 80Br, 1.9), 180 (M+, 78Br, 1.8), 156 (38),
101 (49), 71 (60), 57 (100). Anal. Calcd for C8H5Br: C, 53.05; H,
2.78. Found: C, 52.8; H, 2.6.
Project 20462002 was supported by the National Natural
Science Foundation of China.
Compound 3c: IR (film): ν (cm-1) 3293, 2197, 1587, 1485, 1095, 822;
1H NMR (CDCl3): δ 7.42 (m, J* = 8.4 Hz, 2H), 7.30 (m, J* = 8.4 Hz,
2H), 3.10 (s, 1H); 13C NMR (CDCl3): δ 134.9, 133.4, 128.7, 120.6,
82.5, 78.2; MS: m/z 138 (M+, 37Cl, 31), 136 (M+, 35Cl,100), 135 (88),
111 (59), 69 (46). Anal. Calcd for C8H5Cl: C, 70.33; H, 3.69. Found:
C, 70.5; H, 3.6.
Received 27 October 2007; accepted 31 December 2007
Paper 07/4917
doi: 10.3184/030823407X275928
References
1
(a) M. Masakatsu and K. Keiko, Tetrahedron Lett., 1980, 21, 4021;
(b) E.D. Ames, Synthesis, 1981, 364; (c) N. Shinichi and K. Matsuda,
J. Chem. Soc. Perkin. Trans. 1, 1992, 755; (d) M. Kotora and E.I. Negishi,
Synthesis, 1997, 121; (e) C. Lai, C. Xi, Y. Jiang and R. Hua, Tetrahedron
Lett., 2005, 46, 513.
Compound 3d: IR (film): ν (cm-1) 3290, 2960, 2106, 1607, 1571,
1
1507, 1171, 1031, 832; H NMR (CDCl3): δ 7.42 (m, J* = 8.8 Hz,
2H), 6.83 (m, J* = 8.8 Hz, 2H), 3.80 (s, 3H), 3.00 (s, 1H); 13C NMR
(CDCl3): δ 160.0, 133.6, 114.2, 113.9, 83.7, 75.8, 55.3; MS: m/z 132
(M+, 26), 123 (68), 111 (51), 109 (70), 97 (84), 95 (94), 69 (100), 57
(88), 55 (96). Anal. Calcd for C9H8O: C, 81.79; H, 6.10. Found: C,
81.5; H, 6.2.
2
(a) H.A. Staab and K. Neunhoffer, Synthesis, 1974, 424; (b) M. Rosenblum,
N. Brawn, J. Papenmeier and M. Applebaum, J. Organomet. Chem., 1966,
6, 173.
3
4
W.L. Collier and R.S. Macomber, J. Org. Chem., 1973, 38, 1367.
(a) P.J. Kocienski, J. Org. Chem., 1974, 39, 3285; (b) J.B. Lambert and
E.G. Larson, J. Am. Chem. Soc., 1985, 107, 5443.
Compound 3e: IR (film): ν (cm-1) 3253, 2107, 1594, 1513, 1492,
1344, 855, 752; 1H NMR (CDCl3): δ 8.20 (m, J* = 8.8 Hz, 2H),
7.64 (m, J* = 8.8 Hz, 2H), 3.36 (s, 1H); 13C NMR (CDCl3): δ 146.2,
133.0, 128.9, 123.6, 82.3, 81.6; MS: m/z 147 (M+, 100), 117 (86), 101
(97), 89 (78), 75 (95). Anal. Calcd for C8H5NO2: C, 65.31; H, 3.43.
Found: C, 65.1; H, 3.5.
5
6
(a) E.J. Corey and P.L. Fuchs, Tetrahedron Lett., 1972, 3769. (b) J. Villieras,
P. Pierrot and J.F. Normant, Synthesis, 1975, 458.
(a) K. Sonogashira, Y. Tohda and N. Hagihara, Tetrahedron Lett., 1975,
4467; (b) S. Takahashi, Y. Kuroyama, K. Sonogashira and N. Hagihara,
Synthesis, 1980, 627; (c) R. Chinchilla and C. Najera, Chem. Rev., 2007,
107, 874.
Compound 3f: IR (film): ν (cm-1) 3290, 2923, 2341, 1631, 1598,
PAPER: 07/4917